These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33349884)

  • 41. Preventive chemotherapy reverses covert, lymphatic-associated tissue change in young people with lymphatic filariasis in Myanmar.
    Douglass J; Dykes L; Kelly-Hope L; Gordon S; Leggat P; Aye NN; Win SS; Wai T; Win YY; Nwe TW; Graves P
    Trop Med Int Health; 2019 Apr; 24(4):463-476. PubMed ID: 30706585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lymphatic filariasis: patients and the global elimination programme.
    Mackenzie CD; Lazarus WM; Mwakitalu ME; Mwingira U; Malecela MN
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S41-51. PubMed ID: 19843397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Editorial: Global elimination of lymphatic filariasis: fact or fantasy?
    Gyapong JO; Twum-Danso NA
    Trop Med Int Health; 2006 Feb; 11(2):125-8. PubMed ID: 16451335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes.
    Houston R
    Parasitology; 2000; 121 Suppl():S161-73. PubMed ID: 11386687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India.
    Kerketta AS; Babu BV; Swain BK
    Acta Trop; 2007 Jun; 102(3):159-64. PubMed ID: 17553441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis.
    Perera M; Whitehead M; Molyneux D; Weerasooriya M; Gunatilleke G
    PLoS Negl Trop Dis; 2007 Nov; 1(2):e128. PubMed ID: 18060080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. African regional progress and status of the programme to eliminate lymphatic filariasis: 2000-2020.
    Deribe K; Bakajika DK; Zoure HM; Gyapong JO; Molyneux DH; Rebollo MP
    Int Health; 2020 Dec; 13(Suppl 1):S22-S27. PubMed ID: 33349875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Burden of lymphatic filariasis morbidity in an area of low endemicity in Brazil.
    Netto MJ; Bonfim C; Brandão E; Aguiar-Santos AM; Medeiros Z
    Acta Trop; 2016 Nov; 163():54-60. PubMed ID: 27427218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wuchereria bancrofti infection in rural tropical guinea savannah communities: Rapid epidemiological assessment using immunochromatographic card test and prevalence of hydrocoele.
    Ivoke N; Ezeabikwa BO; Ivoke ON; Ekeh FN; Ezenwaji NE; Odo GE; Onoja US; Eyo JE
    Trop Biomed; 2015 Jun; 32(2):365-75. PubMed ID: 26691265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress toward elimination of lymphatic filariasis--Togo, 2000--2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(29):989-91. PubMed ID: 21796097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated morbidity management for lymphatic filariasis and podoconiosis, Ethiopia.
    Deribe K; Kebede B; Tamiru M; Mengistu B; Kebede F; Martindale S; Sime H; Mulugeta A; Kebede B; Sileshi M; Mengiste A; McPherson S; Fentaye A
    Bull World Health Organ; 2017 Sep; 95(9):652-656. PubMed ID: 28867846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Situational analysis of lymphatic filariasis morbidity in Ahanta West District of Ghana.
    Stanton MC; Best A; Cliffe M; Kelly-Hope L; Biritwum NK; Batsa L; Debrah A
    Trop Med Int Health; 2016 Feb; 21(2):236-44. PubMed ID: 26584839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A systematic review of alternative surveillance approaches for lymphatic filariasis in low prevalence settings: Implications for post-validation settings.
    Riches N; Badia-Rius X; Mzilahowa T; Kelly-Hope LA
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008289. PubMed ID: 32396575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How community engagement strategies shape participation in mass drug administration programmes for lymphatic filariasis: The case of Luangwa District, Zambia.
    Silumbwe A; Halwindi H; Zulu JM
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007861. PubMed ID: 31774820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme.
    Mohammed KA; Molyneux DH; Albonico M; Rio F
    Trends Parasitol; 2006 Jul; 22(7):340-4. PubMed ID: 16713740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic Costs and Benefits of Community-Based Lymphedema-Management Programs for Lymphatic Filariasis in India.
    Sawers L; Stillwaggon E
    Am J Trop Med Hyg; 2020 Jul; 103(1):295-302. PubMed ID: 32653050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seventh meeting of the Global Alliance to Eliminate Lymphatic Filariasis: reaching the vision by scaling up, scaling down, and reaching out.
    Brady M;
    Parasit Vectors; 2014 Jan; 7():46. PubMed ID: 24450283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.